Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial aims to protect Kids' kidneys from rare disease

NCT ID NCT07024563

Recruiting now Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether the drug ravulizumab can help children and teenagers (ages 2-18) with IgA nephropathy, a kidney disease where the immune system attacks the kidneys. Participants will receive the drug through an IV to see if it reduces protein in their urine and slows kidney damage over 106 weeks. The goal is to control the disease and prevent it from getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOGLOBULIN A NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    NOT_YET_RECRUITING

    Palo Alto, California, 94304, United States

  • Research Site

    RECRUITING

    Aurora, Colorado, 80045, United States

  • Research Site

    RECRUITING

    Beijing, 100045, China

  • Research Site

    RECRUITING

    Shanghai, 201102, China

  • Research Site

    RECRUITING

    Genova, 16147, Italy

  • Research Site

    RECRUITING

    Roma, 00165, Italy

  • Research Site

    RECRUITING

    Torino, 10126, Italy

  • Research Site

    RECRUITING

    Wakayama, 641-8510, Japan

  • Research Site

    RECRUITING

    Seoul, 03080, South Korea

  • Research Site

    RECRUITING

    Barcelona, 08035, Spain

  • Research Site

    RECRUITING

    Barcelona, 8950, Spain

  • Research Site

    RECRUITING

    Seville, 41013, Spain

  • Research Site

    RECRUITING

    Taipei, 10002, Taiwan

  • Research Site

    RECRUITING

    Taoyuan District, 333, Taiwan

Conditions

Explore the condition pages connected to this study.

HENOCH-SCHONLEIN PURPURA NEPHRITIS IGA VASCULITIS IGAN IGAVN IMMUNOGLOBULIN A NEPHROPATHY IMMUNOGLOBULIN A VASCULITIS ASSOCIATED NEPHRITIS